USFDA classifies inspection of Cipla's Goa facility as Official Action Indicated
The Company does not believe that this will have any material impact on the US business at this stage. The Company has a strong track record of maintaining the highest standard of compliance and will work closely with the agency to comprehensively address the observations received.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content